Two Maine biotech companies have announced news regarding recent changes, Portland Press Herald reports. Scarborough based Fluid Imaging Technologies, BAM member and developer of a specialized device which allows for viewing particles in fluid, just introduced the expansion of their highly popular product, FlowCam, in the 50th country, giving the company a footprint in 7 continents. Shifting gears, another biotech startup company, Biovation of Boothbay is closing its doors. After seven years of developing and marketing innovative anti-microbial fiber products, the startup has laid off employees and put its assets up for sale. “With any risk comes the possibility of failure” said Biovation’s CEO Kerem Durdag about the recent development “It is my strongest belief that we as a state have to culturally get comfortable with the idea of risk if we are to be economically viable and have multiplier (effects) for our kids. And hence we have to see the value of failure. We just have to.” Read full article
Related Posts
Maine’s life sciences sector growth could outpace other industries
Maine’s $2.3 billion life sciences sector, which employed close to 10,000 people in 2024, will outpace the growth of many other...
IDEXX gets wiggle room to buy back more shares
IDEXX Laboratories Inc. (Nasdaq: IDXX), a Westbrook-based maker of veterinary diagnostics and software, has the green light from its board of...
Maine’s first accredited lab for PFAS testing is expanding to meet demand
NORRIDGEWOCK, Maine — This week, the Biden administration moved to prevent dangerous “forever chemicals” from being released onto the market after a less...